A detailed history of Xtx Topco LTD transactions in Bio Affinity Technologies, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 10,616 shares of BIAF stock, worth $8,811. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,616
Previous 11,264 5.75%
Holding current value
$8,811
Previous $23,000 60.87%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

SELL
$0.88 - $2.18 $570 - $1,412
-648 Reduced 5.75%
10,616 $9,000
Q3 2024

Nov 14, 2024

BUY
$1.32 - $2.82 $14,868 - $31,764
11,264 New
11,264 $23,000

Others Institutions Holding BIAF

About bioAffinity Technologies, Inc.


  • Ticker BIAF
  • Exchange
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 2,727,580
  • Market Cap $2.26M
  • Description
  • bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is b...
More about BIAF
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.